PRIME THERAPEUTICS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at PRIME THERAPEUTICS is $137,370, based on 46 certified filings from FY 2020 to FY 2026. This is 14% higher than the national H-1B median salary of $120,000. Compensation at PRIME THERAPEUTICS reflects their market positioning, with entry-level roles starting around $125,445 and senior positions reaching $166,400 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at PRIME THERAPEUTICS range from $118,430 at the 10th percentile to $166,400 at the 90th percentile, showing a $47,970 spread across experience levels and roles. The 25th percentile is $125,445 and the 75th percentile is $150,000.

Yes, PRIME THERAPEUTICS actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 47 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 46 certified applications and a 0% denial rate, PRIME THERAPEUTICS maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), PRIME THERAPEUTICS filed 2 H-1B applications, with 2 certified and 0 denied. Over 7 years of data, PRIME THERAPEUTICS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

PRIME THERAPEUTICS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 47 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating PRIME THERAPEUTICS as a potential H-1B sponsor.

This is an excellent approval rate, indicating PRIME THERAPEUTICS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

PRIME THERAPEUTICS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 46 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles PRIME THERAPEUTICS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at PRIME THERAPEUTICS:

The most frequently sponsored role is Senior Software Engineer with 7 filings at a median salary of $134,640. This is followed by Lead Software Engineer (4 filings) and Lead Systems Engineer.

PRIME THERAPEUTICS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where PRIME THERAPEUTICS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top PRIME THERAPEUTICS H-1B locations:

The largest H-1B hub for PRIME THERAPEUTICS is Eagan, MN with 35 filings at a median salary of $139,318. The highest-paying location is Frisco, TX at $166,400 median. Salaries range from $114,565 to $166,400 across office locations.

PRIME THERAPEUTICS's median H-1B salary has increased by +38% from FY 2020 ($113,776) to FY 2026 ($156,703). Tracking salary trends over time reveals how PRIME THERAPEUTICS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at PRIME THERAPEUTICS.

Year-by-year breakdown:

• FY 2022: $133,148 (2 certified)
• FY 2023: $130,000 (15 certified)
• FY 2024: $159,120 (12 certified)
• FY 2025: $142,000 (7 certified)
• FY 2026: $156,703 (2 certified)

This 38% growth reflects strong compensation adjustments at PRIME THERAPEUTICS, keeping pace with market demands for H-1B talent.

PRIME THERAPEUTICS primarily files H-1B applications at Wage Level IV, accounting for 100% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making PRIME THERAPEUTICS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 100% of positions at Level II or higher, PRIME THERAPEUTICS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

PRIME THERAPEUTICS's median H-1B salary of $137,370 is 14% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating PRIME THERAPEUTICS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare PRIME THERAPEUTICS's offerings with similar companies in your field for a more accurate assessment.

PRIME THERAPEUTICS offers above-average H-1B compensation. Combined with their 46 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. PRIME THERAPEUTICS's higher proportion of Level III-IV positions (100%) may benefit from wage-based lottery prioritization.

With 46 certified filings, PRIME THERAPEUTICS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.